高级检索
当前位置: 首页 > 详情页

Lanthanum promoting bone formation by regulating osteogenesis, osteoclastogenesis and angiogenesis

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ 统计源期刊 ◇ CSCD-C ◇ 卓越:梯队期刊

机构: [1]Hebei Univ, Affiliated Hosp, Hebei Key Lab Chron Kidney Dis & Bone Metab, Baoding 071000, Peoples R China [2]Hebei Univ, Coll Chem & Environm Sci, Key Lab Med Chem & Mol Diag, Key Lab Chem Biol Hebei Prov,Minist Educ, Baoding 071002, Peoples R China
出处:
ISSN:

关键词: Lanthanum Bone microenvironment Osteogenic differentiation Angiogenesis Rare earths

摘要:
With lanthanum (La) in agriculture, medicine, and the chemical industry, La shows accumulation in the body, especially in the bone, because of its similar structure to calcium. Moreover, La has a direct role in bone formation regulating osteoblasts and osteoclasts. Nevertheless, bone formation is complex under the regulation of osteogenesis, osteoclastogenesis, and angiogenesis in the bone microenvironment. It is difficult to comprehensively understand the regulation of bone homeostasis from a single kind of cell. Herein, some bone microenvironment-related cells and mouse calvaria culture models were used to study the regulatory effect of La-based compound-lanthanum nitrate (La(NO3)3) on bone formation. La(NO3)3 has good biological safety, and the osteogenic differentiation is significantly increased under La(NO3)3 treatment for bone marrow mesenchymal stem cells (BMMSC). In contrast, the differentiation, maturation, and bone erosion ability of osteoclasts are significantly decreased. Meanwhile, the angiogenesis ability of human umbilical vein endothelial cells (HUVEC) is significantly promoted when treated with La(NO3)3. Furthermore, bone metabolism and angiogenesis are improved under La(NO3)3 treatment in the calvaria ex vivo culture model and BMMSC-HUVEC co-culture system. These results suggest that La has the beneficial effect of promoting bone metabolism and improving bone formation in the bone microenvironment. (c) 2023 Chinese Society of Rare Earths. Published by Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2025]版:
最新[2025]版:
大类 | 1 区 化学
小类 | 1 区 应用化学
JCR分区:
出版当年[2024]版:
最新[2023]版:
Q1 CHEMISTRY, APPLIED

影响因子: 最新[2023版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]Hebei Univ, Affiliated Hosp, Hebei Key Lab Chron Kidney Dis & Bone Metab, Baoding 071000, Peoples R China
通讯作者:
通讯机构: [1]Hebei Univ, Affiliated Hosp, Hebei Key Lab Chron Kidney Dis & Bone Metab, Baoding 071000, Peoples R China [2]Hebei Univ, Coll Chem & Environm Sci, Key Lab Med Chem & Mol Diag, Key Lab Chem Biol Hebei Prov,Minist Educ, Baoding 071002, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15101 今日访问量:2 总访问量:962 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号